Hematology/oncology clinics of North AmericaHumansMelanomaImmunotherapyDisease ManagementSkin Neoplasms
Management of Locoregional Melanoma.
Shannon K Swisher, Keith A Delman
Published: 202610.1016/j.hoc.2025.07.005
Abstract
Standard use of adjuvant immunotherapy has significantly improved clinical outcomes in melanoma. Neoadjuvant immunotherapy has further enhanced these benefits in the setting of advanced disease. Lack of a reliable biomarker to monitor treatment respo…
Preview only. Read the full abstract at the source